Trojan Bio

Trojan Bio is at the forefront of biotechnology research, pioneering a novel class of therapeutic antibodies designed for the effective treatment of various cancers. Harnessing viral specific immunity, Trojan Bio's innovative approach involves integrating viral peptides into Trojan antibodies, efficiently activating the immune system to eradicate cancer cells.

Located at Inter-Lab (Merck's Incubator) in Israel, Trojan Bio is dedicated to advancing cancer therapeutics through groundbreaking research and development. The company is focused on creating solutions that enhance the body's natural ability to fight cancer, promising a more effective and less invasive treatment option.

Trojan Bio is committed to improving patient outcomes by developing cutting-edge therapies. We invite the management team at Trojan Bio to create a customized and exclusive company showcase and product listing on our platform, to further highlight the company's innovative work and commercial potential.